• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

1.160 -0.060 (-4.92%)
Official Closing Price Updated: 8:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cel-Sci Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
CEL-SCI Reports Fiscal 2021 Financial Results and Clinical & Corporate Developments
December 22, 2021
From CEL-SCI Corporation
Via Business Wire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
December 16, 2021
Good morning, trader! We're getting right into the swing of things with a breakdown of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
CEL-SCI Corporation Completes Commercial-Scale Buildout of Multikine Manufacturing Facility
October 22, 2021
From CEL-SCI Corporation
Via Business Wire
Analyzing CEL-SCI's Unusual Options Activity ↗
August 10, 2021
On Tuesday, shares of CEL-SCI (AMEX:CVM) saw unusual options... 
Via Benzinga
Why CEL-SCI Shares Are Getting Hammered Today ↗
June 30, 2021
CEL-SCI Corporation (NASDAQ:CVM) shares are trading lower b... 
Via Benzinga
News headline image
Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive ↗
October 19, 2021
On CNBC’s "Mad Money Lightning Ro... 
Via Benzinga
News headline image
CEL-SCI Corporation (NYSE:CVM) Investor Investigation over Potential Wrongdoing ↗
September 07, 2021
San Diego, CA -- (SBWIRE) -- 09/07/2021 -- Certain directors of CEL-SCI Corporation are under investigation over potential breaches of fiduciary duties. 
Via SBWire
News headline image
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge ↗
August 17, 2021
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
CEL-SCI Corporation Reports Third Quarter Fiscal 2021 Financial Results
August 16, 2021
From CEL-SCI Corporation
Via Business Wire
News headline image
Understanding CEL-SCI's Unusual Options Activity ↗
July 19, 2021
CEL-SCI (AMEX:CVM) shares experienced unusual options activity on Monday. The stock price moved down to $7.68 following the option alert. Sentiment: NEUTRAL Option Type: TRADE... 
Via Benzinga
News headline image
CEL-SCI Corporation (NYSE:CVM) Shareholder Notice: Investigation over Possible Violations of Securities Laws ↗
July 13, 2021
San Diego, CA -- (SBWIRE) -- 07/13/2021 -- CEL-SCI Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Unusual Options Activity Insight: CEL-SCI ↗
July 12, 2021
Shares of CEL-SCI (AMEX:CVM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $9.35. Sentiment: BEARISH Option Type:... 
Via Benzinga
News headline image
Why CEL-SCI Stock Soared Today ↗
July 07, 2021
The company attempted to clarify "confusion" related to its recent late-stage clinical results. 
Via The Motley Fool
News headline image
CEL-SCI Corporation Issues Letter to Shareholders
July 07, 2021
From CEL-SCI Corporation
Via Business Wire
News headline image
3 Biotechs to Avoid Like the Plague in July ↗
July 06, 2021
Generally speaking, biotech is a pretty innovative industry -- with a few notable bad apples. 
Via The Motley Fool
News headline image
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available
July 02, 2021
From CEL-SCI Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
July 02, 2021
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows. Points of Interest: Autohome (NYSE:ATHM) was the largest firm by market cap to set a new 52-week low... 
Via Benzinga
News headline image
72 Biggest Movers From Yesterday ↗
July 01, 2021
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN... 
Via Benzinga
Topics Initial Public Offering
News headline image
CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021
June 30, 2021
From CEL-SCI Corporation
Via Business Wire
News headline image
51 Stocks Moving In Wednesday's Mid-Day Session ↗
June 30, 2021
Gainers Cuentas Inc. (NASDAQ: CUEN) shares jumped 176.6% to $7.69. The stock spiked following a press release saying "WaveMax to Implement the World's First Shared Wifi6... 
Via Benzinga
News headline image
Will All End Well for This Popular Reddit Biotech? ↗
June 30, 2021
Everything went the wrong way for Cel-Sci. 
Via The Motley Fool
News headline image
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher ↗
June 28, 2021
Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
60 Biggest Movers From Yesterday ↗
June 29, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
News headline image
Nasdaq Hits Intraday Highs as Treasury Yields Retreat ↗
June 28, 2021
The Dow Jones Industrial Average is 216 points lower at midday, erasing this morning's marginal gains amid growing pressures on energy and transportation stocks. 
Via Talk Markets
Topics Stocks
News headline image
Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump ↗
June 28, 2021
Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
44 Stocks Moving In Monday's Mid-Day Session ↗
June 28, 2021
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook ↗
June 28, 2021
Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
CEL-SCI's Immunotherapy Achieves Survival Benefit Of 14% Exceeding Pre-Defined 10% In Head & Cancer Patients ↗
June 28, 2021
CEL-SCI Corporation (NYSE: CVM) has announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell... 
Via Benzinga
News headline image
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study
June 28, 2021
From CEL-SCI Corporation
Via Business Wire
News headline image
24 Stocks Moving in Monday's Pre-Market Session ↗
June 28, 2021
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap